Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2022 Sep;22(5):396–400. doi: 10.7861/clinmed.2022-cme-meningitis

The management of acute meningitis: an update

Emma Carter A,, Fiona McGill B
PMCID: PMC9594998  PMID: 36507811

ABSTRACT

Meningitis remains an important cause of mortality and morbidity. Clinicians should be alert to this diagnosis and have a low threshold for investigation and treatment of meningitis. This article provides an update of current evidence and existing guidelines for the management of suspected acute meningitis in adults in the UK.

KEYWORDS: infectious diseases, meningitis, Streptococcus pneumoniae, Neisseria meningitidis, enteroviruses

Key points

  • Lumbar puncture should be performed as soon as possible in all cases of suspected meningitis, unless contraindicated, in order to determine the aetiology, guide treatment decisions, and prevent unnecessary treatment and prolonged hospital stays.

  • Brain imaging is not required in the majority of cases prior to lumbar puncture and results in unnecessary delays in lumbar puncture and antibiotic initiation.

  • Steroids should be initiated just prior to or in conjunction with antibiotics in all cases of suspected bacterial meningitis.

  • Important risk factors for specific aetiologies should be ascertained and guide empirical antibiotic decisions; for example, relative immunocompromise including age >60 years, chronic disease and alcohol excess (risk of Listeria monocytogenes) and a travel history to areas with a high incidence of penicillin-resistant Streptococcus pneumoniae.

  • Mortality from bacterial meningitis remains significant and future treatments are being developed that aim to reduce the inflammation associated with the disease.

Definitions

Meningitis is inflammation of the meninges and is a pathological diagnosis. Elevated cerebrospinal fluid (CSF) leukocytes and proteins are used as proxy markers of inflammation. Bacterial or viral meningitis are diagnosed when the relevant pathogen is identified in the CSF along with an appropriate clinical syndrome and evidence of inflammation in the CSF.1

Aetiology

A viral cause is identified in up to half of meningitis cases where a cause is found.2 Enteroviruses are the most common cause followed by herpes simplex virus (HSV) and varicella-zoster virus (VZV). Less common causes can be linked to travel such as Toscana virus.2–4 Many cases of viral meningitis are assumed when no pathogen is detected.

Streptococcus pneumoniae and Neisseria meningitidis are the most common bacterial causes in the UK. Other causes such as Haemophilus influenzae, Listeria monocytogenes, Mycobacterium tuberculosis and fungi are less common. In up to 40% of patients, no cause is identified.2,3,5

Clinical features

Clinical features of meningitis alone cannot be used to discriminate between viral and bacterial meningitis. One study showed that 95% of patients with bacterial meningitis had at least two out of fever, headache, neck stiffness or altered consciousness but these can also occur in other diagnoses.5,6 Therefore, meningitis should be considered in any patient presenting with two or more of these symptoms but lumbar puncture (LP) is essential, unless contraindicated, to diagnose or rule out meningitis, and to determine the aetiology.

Certain features can make a specific aetiology more likely. A rash is seen in approximately half the cases of meningococcal meningitis but can be seen in other causes of viral and bacterial meningitis.2 Listeria meningitis is more likely with a history of relative immunocompromise (such as older age, diabetes, chronic disease and alcohol excess) as well as overt immunocompromise.7 Other important points include travel history, HIV status, extra-meningeal foci of infection (such as otitis and sinusitis (more common in pneumococcal meningitis)), features of sepsis or contact with another meningitis case.1,6

Investigations

Lumbar puncture

LP is the key investigation as it enables confirmation of meningitis and reveals the aetiology. In the UK, the median time from admission to LP is 17 hours despite national recommendations for an LP to be performed within 1 hour of arrival to hospital and preferably prior to antibiotics.3 The likelihood of detecting a pathogen decreases over time and, while getting an LP done within an hour is not always possible, it should be done as soon as is practically possible.2,8 In patients with predominantly sepsis or a rapidly evolving rash, LP is not recommended (Box 1).1

Box 1.

Contraindications to immediate lumbar puncture

Indications for brain imaging prior to lumbar puncture
  • Focal neurological signs

  • Presence of papilloedemaa

  • Continuous or uncontrolled seizures

  • Glasgow coma score ≤12

Other contraindications to immediate lumbar puncture
  • Signs of severe sepsis or rapidly evolving rash

  • Respiratory or cardiac compromise

  • Anticoagulant therapy / antiplatelet therapy / known thrombocytopenia or clotting abnormalityb

  • Infection at the site of lumbar puncture

Once stable and meningitis is still likely, lumbar puncture may still be diagnostically useful, even after several days.

aShould always be attempted but inability to view the fundus is not a contraindication to lumbar puncture.

bUnless a clotting abnormality is suspected lumbar puncture should not be delayed to await blood test results.

Cerebrospinal fluid cell count

Van de Beek and colleagues reported that >90% of adults with bacterial meningitis had a CSF leukocyte count >100 cells/μL.6 Absence of leukocytosis makes meningitis unlikely, but does not rule it out. A Danish study found an absence of leukocytosis in 2% of patients with bacterial meningitis, with a higher frequency in pneumococcal meningitis, a finding that was replicated in a Dutch study, which found immunocompromise was also a risk factor.9,10

Cerebrospinal fluid leukocyte differential

A predominance of neutrophils in the CSF suggests bacterial meningitis while predominance of lymphocytes suggests viral meningitis. Important exceptions include a predominance of lymphocytes in bacterial meningitis if antibiotics have been given prior to LP and with certain bacteria (such as Listeria monocytogenes and in tuberculous meningitis).11 A predominance of neutrophils can be seen in early viral meningitis as well, especially with enterovirus.12

CSF biochemistry

CSF protein, glucose and lactate give an indication as to the aetiology of meningitis but are not definitive (Table 1).1 In a recent cohort study, a CSF:blood glucose ratio <0.6 detected all cases of bacterial meningitis but was not specific.5 A CSF protein of <0.6 g/L makes bacterial meningitis unlikely.13 CSF lactate has a high sensitivity and specificity in distinguishing between bacterial and viral meningitis if antibiotics have not been given beforehand, a cut off of 35 mg/dL has been suggested to have the best sensitivity for distinguishing between bacterial and viral meningitis.14

Table 1.

Cerebrospinal fluid parameters for different aetiologies of meningitis1

Normal Bacterial Viral Tuberculous Fungal
Opening pressure, cm CSF 12–20 Raised Normal / mildly raised Raised Raised
Appearance Clear Turbid, cloudy, purulent Clear Clear or cloudy Clear or cloudy
CSF WCC, cells/μL <5 Raised (usually >100)a Raised (usually 5–1,000)a Raised (usually 5–500)a Raised (usually 5–500)a
Predominant cell type n/a Neutrophilsb Lymphocytesc Lymphocytesd Lymphocytes
CSF protein, g/L <0.4 Raised Mildly raised Markedly raised Raised
CSF glucose, mmol 2.6–4.5 Very low Normal / slightly low Very low Low
CSF:plasma glucose ratio >0.66 Very low Normal / slightly low Very low Low

Consult local laboratory values that may vary. A traumatic lumbar puncture may falsely elevate the white cell count, a correction factor of 1:1,000 white cells to red cells is often used.

aOccasionally the cerebrospinal fluid white cell count may be normal (especially in children and the immunocompromised).

bMay be lymphocytic if antibiotics given before lumbar puncture or with certain bacteria, eg Listeria monocytogenes.

cMay be neutrophilic in enteroviral meningitis.

dMay be neutrophilic early in the course of disease. CSF = cerebrospinal fluid; WCC = white cell count. Reproduced with permission from McGill F, Heyderman RS, Michael BD et al. The UK Joint Specialist Societies Guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 2016;72:405–38 under CC BY-NC-ND 4.0 licence.

Clinical prediction models

A recent systematic review and validation of clinical prediction models found that none of the tested models had both sufficient sensitivity and specificity to be recommended for routine clinical use.15

Pathogen detection

CSF microscopy and culture

CSF microscopy with Gram stain is useful for rapid detection of bacteria. CSF culture is diagnostic in 70%–85% of cases prior to antibiotic exposure.11 However, in a recent UK study, CSF culture was positive in only 23% of cases of bacterial meningitis when the median time to LP was several hours after antibiotic administration.2 CSF sterilisation can occur within 2 hours and 4 hours of antibiotic administration for meningococci and pneumococci, respectively.8

CSF polymerase chain reaction

CSF polymerase chain reaction (PCR) can rapidly detect viruses and bacteria in the CSF with high specificity. It is the gold standard for detection of viruses and is increasingly relied upon in the diagnosis of bacterial meningitis, especially when antibiotics have been given prior to LP. Over 50% of meningococcal disease is diagnosed by PCR alone in the UK.16 Multiplex PCR, which can detect multiple pathogens at once, are increasingly being used with reasonable diagnostic accuracy reported.17

Whole genome sequencing techniques

Although not currently in routine clinical use, studies have shown that different sequencing methods on CSF identified unexpected pathogens not detected by conventional methods. However, they failed to detect some pathogens found by conventional microbiological testing.4,18 Further work is needed to evaluate the clinical impact of such techniques.

Blood tests

Blood cultures should be taken in all cases of suspected meningitis prior to administration of antibiotics (Fig 1).1 Blood meningococcal and pneumococcal PCR are also recommended and have been shown to substantially increase detection of meningococcal disease, and remain positive for several days after antibiotic initiation.2,19

Fig 1.

Fig 1.

Recommended investigations in acute meningitis and meningococcal sepsis. CSF = cerebrospinal fluid; CRP = C-reactive protein; HSV = herpes simplex virus; LP = lumbar puncture; PCR = polymerase chain reaction; rRNA = ribosomal ribonucleic acid; VZV = varicella-zoster virus. Adapted with permission from McGill F, Heyderman RS, Michael BD et al. The UK Joint Specialist Societies Guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 2016;72:405–38 under CC BY-NC-ND 4.0 licence.

Although some studies have shown procalcitonin has good sensitivity and specificity for differentiating bacterial from viral meningitis, it should be interpreted with the rest of the clinical picture not be the sole determinant.20

Swabs

Throat, nasopharyngeal and stool swabs are useful for detecting enteroviruses if the CSF PCR is negative. Methicillin-resistant Staphylococcus aureus screening swabs should be taken. A bacterial throat swab should also be taken from cases with suspected meningococcal disease to provide information about the infecting strain in PCR-confirmed cases.1

Brain imaging

In the majority of cases of suspected meningitis brain imaging is not required and LP can be performed without. Despite this, a UK study showed that 94% of patients had brain imaging prior to LP and an earlier study showed brain imaging resulted in delays in LP of 10 hours.2,3 Furthermore, brain imaging prior to LP results in delays to antibiotic initiation, which leads to increased mortality.21 An urgent computed tomography should be performed if there are clinical signs of brain shift that may indicate a contraindication to LP. When brain shift is identified, liaison with critical care and neurosurgical teams are essential.1 Imaging should also be considered if there has been a deterioration following an initial improvement to look for complications, such as subdural empyema.

Treatment

Stabilisation of the patient's airway, breathing and circulation is an immediate priority. The patient's consciousness level should be documented using the Glasgow coma score (GCS). A decision regarding the need for senior review and/or intensive care admission should be made within the first hour. A GCS ≤12 should prompt discussion with critical care for consideration of intubation. All patients should be cared for with input from an infection specialist (Fig 2).1

Fig 2.

Fig 2.

Antimicrobial treatment algorithm. aSerum vancomycin trough concentrations of 15–20 μg/mL should be aimed for. bd = twice a day; IV = intravenous; MIC = minimal inhibitory concentration; PO = per oral; tds = three times a day.

In patients with predominantly sepsis or a rapidly evolving rash, antibiotics should be given immediately after blood cultures have been taken. The surviving sepsis guidelines should be followed in patients with sepsis.22 A recent meta-analysis has shown that delays of over 2 hours in antibiotic administration in bacterial meningitis are associated with a doubling in mortality.21 Therefore, antibiotics should be administered as soon as possible and certainly within 2 hours in suspected meningitis without sepsis.

Steroids

A Cochrane review found that steroids led to a small reduction in mortality in pneumococcal meningitis and reduced hearing loss and neurological sequelae for all causes.23 They concluded that current data supports their use in high-income settings in acute meningitis but not in low-income settings.23

Current UK guidance recommends that intravenous dexamethasone 10 mg 6 hourly should be commenced on admission shortly before or simultaneously with antibiotics and up to 12 hours after for patients with suspected meningitis.1 Compliance with this recommendation in the UK is poor, with only 20% of patients given steroids.3 If pneumococcal meningitis is confirmed, dexamethasone should be continued for 4 days.

Antibiotic choice

Consideration should be given to patient risk factors. In those with relative or overt immunocompromise (see details earlier), amoxicillin/ampicillin should be added to cover Listeria. A recent UK study showed that only 28% of patients aged >60 years and 31% of those immunocompromised received anti-listerial antibiotics.3 In those with a travel history to an area with a high prevalence of penicillin-resistant pneumococci, then vancomycin or rifampicin should be added.1

Viral meningitis

There is no specific treatment for viral meningitis, but clinical trials are lacking. Treatment with aciclovir is of proven benefit in herpes encephalitis, therefore, if the patient has encephalitic features, aciclovir should be given. A prospective observational study in the UK showed that 43% of patients with HSV/VZV meningitis received ≥5 days of antivirals despite no evidence showing benefit.2

New treatments

The mortality associated with meningitis is still 10%–20%, much of this is due to associated inflammation. Current trials are aimed at reducing inflammation. An ongoing randomised trial is assessing whether the addition of daptomycin to standard treatment improves outcomes.24 Daptomycin is primarily being used for its anti-inflammatory properties in this context rather than its antimicrobial ones.25 Pre-clinical studies have shown that adjuvant treatment with C5 inhibitors dampen down complement-associated damage and improve outcomes in an experimental model of pneumococcal meningitis.26

References

  • 1.McGill F, Heyderman RS, Michael BD, et al. The UK Joint Specialist Societies Guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults. J Infect 2016;72:405–38. [DOI] [PubMed] [Google Scholar]
  • 2.McGill F, Griffiths MJ, Bonnett LJ, et al. Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis 2018;18:992–1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ellis J, Harvey D, Defres S, et al. Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR). BMJ Open 2022;12:e062698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.McGill F, Tokarz R, Thomson EC, et al. Viral capture sequencing detects unexpected viruses in the cerebrospinal fluid of adults with meningitis. Journal of Infection 2022;84:499–510. [DOI] [PubMed] [Google Scholar]
  • 5.Khatib U, van de Beek D, Lees JA, Brouwer MC. Adults with suspected central nervous system infection: a prospective study of diagnostic accuracy. J Infect 2017;74:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849–59. [DOI] [PubMed] [Google Scholar]
  • 7.Gillespie IA, McLauchlin J, Little CL, et al. Disease presentation in relation to infection foci for non-pregnancy-associated human listeriosis in England and Wales, 2001 to 2007. J Clin Microbiol 2009;47:3301–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001;108:1169–74. [PubMed] [Google Scholar]
  • 9.Vestergaard HH, Larsen L, Brandt C, et al. Normocellular community-acquired bacterial meningitis in adults: a nationwide population-based case series. Ann Emerg Med 2021;77:11–8. [DOI] [PubMed] [Google Scholar]
  • 10.van Soest TM, Chekrouni N, van Sorge NM, Brouwer MC, van de Beek D. Bacterial meningitis presenting with a normal cerebrospinal fluid leukocyte count. J Infect 2022;84:615–20. [DOI] [PubMed] [Google Scholar]
  • 11.Bohr V, Rasmussen N, Hansen B, et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy part iii of a three-part series. J Infect 1983;7:193–202. [DOI] [PubMed] [Google Scholar]
  • 12.Carrol ED, Beadsworth MBJ, Jenkins N, et al. Clinical and diagnostic findings of an echovirus meningitis outbreak in the north west of England. Postgrad Med J 2006;82:60–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.White K, Ostrowski K, Maloney S, Norton R. The utility of cerebrospinal fluid parameters in the early microbiological assessment of meningitis. Diagn Microbiol Infect Dis 2012;73:27–30. [DOI] [PubMed] [Google Scholar]
  • 14.Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect 2011;62:255–62. [DOI] [PubMed] [Google Scholar]
  • 15.van Zeggeren IE, Bijlsma MW, Tanck MW, van de Beek D, Brouwer MC. Systematic review and validation of diagnostic prediction models in patients suspected of meningitis. J Infect 2020;80:143–51. [DOI] [PubMed] [Google Scholar]
  • 16.Heinsbroek E, Ladhani S, Gray S, et al. Added value of PCR-testing for confirmation of invasive meningococcal disease in England. J Infect 2013;67:385–90. [DOI] [PubMed] [Google Scholar]
  • 17.Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire FilmArray meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect 2020;26:281–90. [DOI] [PubMed] [Google Scholar]
  • 18.Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 2019;380:2327–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Newcombe J, Cartwright K, Palmer WH, McFadden J. PCR of peripheral blood for diagnosis of meningococcal disease. J Clin Microbiol 1996;34:1637–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Atallah CJ, Panossian VS, Atallah NJ, Roberts MB, Mansour MK. Extra-pulmonary applications of procalcitonin: an updated literature review. Expert Rev Mol Diagn 2022;22:537–44. [DOI] [PubMed] [Google Scholar]
  • 21.Eisen DP, Hamilton E, Bodilsen J, et al. Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort. Sci Rep 2022;12:672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Society of Critical Care Medicine . Surviving Sepsis Campaign Guidelines 2021. SCCM, 2021. www.sccm.org/Clinical-Resources/Guidelines/Guidelines/Surviving-Sepsis-Guidelines-2021 [Google Scholar]
  • 23.Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2015;2015:CD004405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Centre Hospitalier Universitaire Dijon . Adjunction of daptomycin for the treatment of pneumococcal meningitis: AddaMAP Study. Clinicaltrials.gov, 2021. clinicaltrials.gov/ct2/show/NCT03480191 [Google Scholar]
  • 25.Grandgirard D, Burri M, Agyeman P, Leib SL. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother 2012;56:4289–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kasanmoentalib ES, Valls Seron M, Morgan P, Brouwer MC, van de Beek D. Adjuvant treatment with dexamethasone plus anti-c5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial. J Neuroinflammation 2015;12:149. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES